A kind of synthetic method of β-amino-alpha-hydroxycyclobutanamide hydrochloride
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SUZHOU UUGENE BIOPHARMA
- Publication Date
- 2015-09-09
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a method for synthesizing a boceprevir intermediate, in particular to a method for synthesizing a boceprevir intermediate β-amino-alpha-hydroxycyclobutylbutanamide hydrochloride, which belongs to the technical field of drug synthesis. Background technique
[0002] In 2011, Merck successfully developed a hepatitis C virus (HCV) NS3 / 4A protease inhibitor Boceprevir (Boceprevir), its chemical name is: (1R, 2S, 5S)-N-(4-amino- 1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[(2S)-2-(tert-butylcarbamoylamido)-3,3-dimethylbutyryl] -6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide, CAS registration number: 394730-60-0, the structural formula is:
[0003]
[0004] It is a small molecule inhibitor with high NS3 inhibitory activity discovered during the systematic truncation and modification of amino acid residues on the ketoamide undecapeptide. It can capture the serine in the active site of NS3 and the carbonyl group on its ketoamide Carb...